Causal relationship between nonalcoholic fatty liver disease and different sleep traits: a bidirectional Mendelian randomized study

Background and aims Non-alcoholic fatty liver disease(NAFLD) is common worldwide and has previously been reported to be associated with sleep traits. However, it is not clear whether NAFLD changes sleep traits or whether the changes in sleep traits lead to the onset of NAFLD. The purpose of this study was to investigate the causal relationship between NAFLD and changes in sleep traits using Mendelian randomization. Methods We proposed a bidirectional Mendelian randomization (MR) analysis and performed validation analyses to dissect the association between NAFLD and sleep traits. Genetic instruments were used as proxies for NAFLD and sleep. Data of genome-wide association study(GWAS) were obtained from the center for neurogenomics and cognitive research database, Open GWAS database and GWAS catalog. Three MR methods were performed, including inverse variance weighted method(IVW), MR-Egger, weighted median. Results In total,7 traits associated with sleep and 4 traits associated with NAFLD are used in this study. A total of six results showed significant differences. Insomnia was associated with NAFLD (OR(95% CI)= 2.25(1.18,4.27), P = 0.01), Alanine transaminase levels (OR(95% CI)= 2.79(1.70, 4.56), P =4.71×10-5) and percent liver fat(OR(95% CI)= 1.31(1.03,1.69), P = 0.03). Snoring was associated with percent liver fat (1.15(1.05,1.26), P =2×10-3), alanine transaminase levels (OR(95% CI)= 1.27(1.08,1.50), P =0.04).And dozing was associated with percent liver fat(1.14(1.02,1.26), P =0.02).For the remaining 50 outcomes, no significant or definitive association was yielded in MR analysis. Conclusion Genetic evidence suggests putative causal relationships between NAFLD and a set of sleep traits, indicating that sleep traits deserves high priority in clinical practice. Not only the confirmed sleep apnea syndrome, but also the sleep duration and sleep state (such as insomnia) deserve clinical attention. Our study proves that the causal relationship between sleep characteristics and NAFLD is the cause of the change of sleep characteristics, while the onset of non-NAFLD is the cause of the change of sleep characteristics, and the causal relationship is one-way.

[1]  Pengxiu Dai,et al.  Reprogramming adipose mesenchymal stem cells into islet β-cells for the treatment of canine diabetes mellitus , 2022, Stem cell research & therapy.

[2]  Yongde Peng,et al.  Fat mass and obesity–associated protein promotes liver steatosis by targeting PPARα , 2022, Lipids in health and disease.

[3]  C. A. Shaw,et al.  Genome‐Wide Association Study of NAFLD Using Electronic Health Records , 2021, Hepatology communications.

[4]  J. Lane,et al.  Genetically Proxied Diurnal Preference, Sleep Timing, and Risk of Major Depressive Disorder. , 2021, JAMA psychiatry.

[5]  Brandon Whitcher,et al.  Author response: Genetic architecture of 11 organ traits derived from abdominal MRI using deep learning , 2021 .

[6]  Jie Shi,et al.  Causal associations of short and long sleep durations with 12 cardiovascular diseases: linear and nonlinear Mendelian randomization analyses in UK Biobank. , 2021, European heart journal.

[7]  Jue Liu,et al.  Prevalence of nonalcoholic fatty liver disease in mental disorder inpatients in China: an observational study , 2021, Hepatology International.

[8]  Chun Meng,et al.  MiR-3138 deteriorates the insulin resistance of HUVECs via KSR2/AMPK/GLUT4 signaling pathway , 2021, Cell cycle.

[9]  Yuncheng Lv,et al.  Critical roles of FTO-mediated mRNA m6A demethylation in regulating adipogenesis and lipid metabolism: Implications in lipid metabolic disorders , 2021, Genes & diseases.

[10]  Samuel E. Jones,et al.  Assessing the Causal Role of Sleep Traits on Glycated Hemoglobin: A Mendelian Randomization Study , 2020, medRxiv.

[11]  Y. Bao,et al.  Self-reported snoring is associated with nonalcoholic fatty liver disease , 2020, Scientific Reports.

[12]  George Davey Smith,et al.  Guidelines for performing Mendelian randomization investigations: update for summer 2023 , 2019, Wellcome open research.

[13]  Samuel E. Jones,et al.  Investigating causal relations between sleep traits and risk of breast cancer in women: mendelian randomisation study , 2019, BMJ.

[14]  N. Murphy,et al.  Using Mendelian randomisation to assess causality in observational studies , 2019, Evidence-Based Mental Health.

[15]  M. Fukui,et al.  Short sleep duration is a risk of incident nonalcoholic fatty liver disease: a population-based longitudinal study. , 2019, Journal of gastrointestinal and liver diseases : JGLD.

[16]  V. Vacic,et al.  Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways , 2019, Nature Genetics.

[17]  D. Yadav,et al.  Total Sleep Duration and Risk of Type 2 Diabetes: Evidence-Based On Clinical and Epidemiological Studies. , 2018, Current drug metabolism.

[18]  R. Guleria,et al.  Non-alcoholic fatty liver disease is an independent risk factor for inflammation in obstructive sleep apnea syndrome in obese Asian Indians , 2018, Sleep and Breathing.

[19]  G. Labarca,et al.  Continuous Positive Airway Pressure in Patients With Obstructive Sleep Apnea and Non-Alcoholic Steatohepatitis: A Systematic Review and Meta-Analysis. , 2018, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[20]  C. Benedict,et al.  Association between long sleep duration and increased risk of obesity and type 2 diabetes: A review of possible mechanisms. , 2017, Sleep medicine reviews.

[21]  C. Thongprayoon,et al.  Insomnia and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis , 2017, Journal of postgraduate medicine.

[22]  E. Zeggini,et al.  Genome-wide analysis of health-related biomarkers in the UK Household Longitudinal Study reveals novel associations , 2017, Scientific Reports.

[23]  C. Kushida,et al.  Short Sleep Duration Is Associated With Abnormal Serum Aminotransferase Activities and Nonalcoholic Fatty Liver Disease , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[24]  Yu Xu,et al.  Short sleep duration and longer daytime napping are associated with non‐alcoholic fatty liver disease in Chinese adults , 2017, Journal of diabetes.

[25]  N. Watanabe,et al.  Short sleep duration and health outcomes: a systematic review, meta-analysis, and meta-regression. , 2017, Sleep medicine.

[26]  M. Holmes,et al.  Commentary: Mendelian randomization-inspired causal inference in the absence of genetic data. , 2016, International journal of epidemiology.

[27]  Danny J. Smith,et al.  Cannabis use and risk of schizophrenia: a Mendelian randomization study , 2016, Molecular Psychiatry.

[28]  R. Farré,et al.  Chronic Sleep Disruption Alters Gut Microbiota, Induces Systemic and Adipose Tissue Inflammation and Insulin Resistance in Mice , 2016, Scientific Reports.

[29]  F. Hu,et al.  Nighttime sleep duration and risk of nonalcoholic fatty liver disease: the Dongfeng-Tongji prospective study , 2016, Annals of medicine.

[30]  F. Fischer,et al.  Short sleep duration increases salivary IL-6 production , 2016, Chronobiology international.

[31]  J. Pépin,et al.  Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: Data from randomized trials , 2016, Respirology.

[32]  C. Beglinger,et al.  Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls , 2015, PloS one.

[33]  F. Scheer,et al.  Short sleep duration and dietary intake: epidemiologic evidence, mechanisms, and health implications. , 2015, Advances in nutrition.

[34]  R. Buijs,et al.  Non‐alcoholic fatty liver disease as a consequence of autonomic imbalance and circadian desynchronization , 2015, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[35]  Nuala A Sheehan,et al.  Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome , 2015, Statistics in medicine.

[36]  K. Abe,et al.  The Association between Sleep Duration and Non-Alcoholic Fatty Liver Disease among Japanese Men and Women , 2015, Obesity Facts.

[37]  M. Irwin,et al.  Sleep loss activates cellular inflammation and signal transducer and activator of transcription (STAT) family proteins in humans , 2015, Brain, Behavior, and Immunity.

[38]  Y. Hiasa,et al.  Short sleep duration reduces the risk of nonalcoholic fatty liver disease onset in men: a community-based longitudinal cohort study , 2015, Journal of Gastroenterology.

[39]  A. Thorp,et al.  Relevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome , 2015, Journal of diabetes research.

[40]  G. Davey Smith,et al.  Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.

[41]  M. Hirshkowitz,et al.  National Sleep Foundation's sleep time duration recommendations: methodology and results summary. , 2015, Sleep health.

[42]  M. Buman,et al.  Does nighttime exercise really disturb sleep? Results from the 2013 National Sleep Foundation Sleep in America Poll. , 2014, Sleep medicine.

[43]  D. Barford,et al.  KSR2 Mutations Are Associated with Obesity, Insulin Resistance, and Impaired Cellular Fuel Oxidation , 2013, Cell.

[44]  Yoosoo Chang,et al.  Sleep duration and quality in relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses. , 2013, Journal of hepatology.

[45]  C. Johnson,et al.  Circadian Disruption Leads to Insulin Resistance and Obesity , 2013, Current Biology.

[46]  P. Gehrman,et al.  Sleep duration versus sleep insufficiency as predictors of cardiometabolic health outcomes. , 2012, Sleep medicine.

[47]  Christopher D Byrne,et al.  Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? , 2012, European heart journal.

[48]  M. Gassmann,et al.  Hypoxia Is Present in Murine Atherosclerotic Plaques and Has Multiple Adverse Effects on Macrophage Lipid Metabolism , 2011, Circulation research.

[49]  T. Olds,et al.  Sleep duration or bedtime? Exploring the relationship between sleep habits and weight status and activity patterns. , 2011, Sleep.

[50]  T. VanderWeele,et al.  Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. , 2011, International journal of epidemiology.

[51]  Joseph S. Takahashi,et al.  Circadian Integration of Metabolism and Energetics , 2010, Science.

[52]  E. Bonora,et al.  Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. , 2010, Journal of hepatology.

[53]  Enzo Bonora,et al.  Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. , 2010, The New England journal of medicine.

[54]  Joseph S. Takahashi,et al.  Disruption of the Clock Components CLOCK and BMAL 1 Leads to Hypoinsulinemia and Diabetes , 2012 .

[55]  P. Newsome,et al.  Pathogenesis of non-alcoholic fatty liver disease , 2009, QJM : monthly journal of the Association of Physicians.

[56]  Robert E. Lewis,et al.  KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity. , 2009, Cell metabolism.

[57]  M. Knuiman,et al.  NAFLD as a Risk Factor for the Development of Diabetes and the Metabolic Syndrome: An Eleven-Year Follow-up Study , 2009, The American Journal of Gastroenterology.

[58]  M. Torbenson,et al.  Chronic intermittent hypoxia and acetaminophen induce synergistic liver injury in mice , 2009, Experimental physiology.

[59]  D. Lawlor,et al.  Clustered Environments and Randomized Genes: A Fundamental Distinction between Conventional and Genetic Epidemiology , 2007, PLoS medicine.

[60]  M. Torbenson,et al.  Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[61]  M. Torbenson,et al.  Chronic intermittent hypoxia predisposes to liver injury , 2007, Hepatology.

[62]  S. Shimba,et al.  Brain and muscle Arnt-like protein-1 (BMAL1), a component of the molecular clock, regulates adipogenesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[63]  Fred W. Turek,et al.  Obesity and Metabolic Syndrome in Circadian Clock Mutant Mice , 2005, Science.

[64]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[65]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference , 2003, Hepatology.

[66]  K. Spiegel,et al.  Impact of sleep debt on metabolic and endocrine function , 1999, The Lancet.

[67]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[68]  A. Marotta,et al.  Liver Steatosis and Fibrosis in OSA patients After Long-term CPAP Treatment: A Preliminary Ultrasound Study. , 2016, Ultrasound in medicine & biology.

[69]  G. Musso,et al.  Association of obstructive sleep apnoea with the presence and severity of nonalcoholic fatty liver disease. A systematic review and metaanalysis , 2013 .